Smith & Wesson Brands (SWBI) EBT Margin (2010 - 2026)

Smith & Wesson Brands has disclosed EBT Margin across 17 years of filings, most recently posting 11.66% for Q2 2026.

• In Q2 2026, EBT Margin rose 287.0% year-over-year to 11.66%; the TTM figure through Apr 2026 stood at 4.79% (up 73.0% YoY), while the FY2026 annual figure was 4.79%, up 73.0% from the prior year.
• EBT Margin climbed to 11.66% in Q2 2026, from 3.96% in the prior quarter.
• Over the last five years, EBT Margin for SWBI reached as high as 25.78% in Q2 2022 and fell as low as 4.82% in Q3 2025.
• The 5-year median for EBT Margin is 6.21% (2022), against an average of 8.25%.
• Annual changes were most pronounced in 2022 — EBT Margin sank 3149 bps — and 2024, when it jumped 957 bps.
• A 5-year view of EBT Margin shows it stood at 10.66% in 2022, then plunged by 75 bps to 2.61% in 2023, then surged by 81 bps to 4.71% in 2024, then plunged by 49 bps to 2.41% in 2025, then soared by 383 bps to 11.66% in 2026.
• According to Business Quant data, EBT Margin over the past three periods registered 11.66%, 3.96%, and 2.41% for Q2 2026, Q1 2026, and Q4 2025 respectively.